Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplants.
Transfusion | 2012-01-01 | PMID 21745212
Thakur Archana, Sorenson Carly, Norkina Oxana and 3 more
